title: Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver.
abstract: Despite numerous reports citing the acute hepatotoxicity caused by 3,4-methylenedioxymethamphetamine (MDMA) (ecstasy), the underlying mechanism of organ damage is poorly understood. We hypothesized that key mitochondrial proteins are oxidatively modified and inactivated in MDMA-exposed tissues. The aim of this study was to identify and investigate the mechanism of inactivation of oxidatively modified mitochondrial proteins, prior to the extensive mitochondrial dysfunction and liver damage following MDMA exposure. MDMA-treated rats showed abnormal liver histology with significant elevation in plasma transaminases, nitric oxide synthase, and the level of hydrogen peroxide. Oxidatively modified mitochondrial proteins in control and MDMA-exposed rats were labeled with biotin-N-maleimide (biotin-NM) as a sensitive probe for oxidized proteins, purified with streptavidin-agarose, and resolved using 2-DE. Comparative 2-DE analysis of biotin-NM-labeled proteins revealed markedly increased levels of oxidatively modified proteins following MDMA exposure. Mass spectrometric analysis identified oxidatively modified mitochondrial proteins involved in energy supply, fat metabolism, antioxidant defense, and chaperone activities. Among these, the activities of mitochondrial aldehyde dehydrogenase, 3-ketoacyl-CoA thiolases, and ATP synthase were significantly inhibited following MDMA exposure. Our data show for the first time that MDMA causes the oxidative inactivation of key mitochondrial enzymes which most likely contributes to mitochondrial dysfunction and subsequent liver damage in MDMA-exposed animals.
authors.affiliation: Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892-9410, USA.
authors.forename: Kwan-Hoon
authors.initials: KH
authors.lastname: Moon
authors.forename: Vijay V
authors.initials: VV
authors.lastname: Upreti
authors.forename: Li-Rong
authors.initials: LR
authors.lastname: Yu
authors.forename: Insong J
authors.initials: IJ
authors.lastname: Lee
authors.forename: Xiaoying
authors.initials: X
authors.lastname: Ye
authors.forename: Natalie D
authors.initials: ND
authors.lastname: Eddington
authors.forename: Timothy D
authors.initials: TD
authors.lastname: Veenstra
authors.forename: Byoung-Joon
authors.initials: BJ
authors.lastname: Song
mesh_terms: D000818:Animals; D001710:Biotin / Q000737:chemistry; D006213:Hallucinogens / Q000494:pharmacology*; D006861:Hydrogen Peroxide / Q000378:metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008297:Male; D008301:Maleimides / Q000737:chemistry; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000378:metabolism; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000097:blood; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D051381:Rats; D017207:Rats, Sprague-Dawley; D053719:Tandem Mass Spectrometry / Q000379:methods; D000637:Transaminases / Q000097:blood
chemical_list: D006213:Hallucinogens; D008301:Maleimides; C043592:maleimide; D001710:Biotin; D006861:Hydrogen Peroxide; D019001:Nitric Oxide Synthase; D000637:Transaminases; D018817:N-Methyl-3,4-methylenedioxyamphetamine
references.citation: J Biol Chem. 2007 Nov 2;282(44):31900-8
references.pmid: 17848570
references.citation: J Biol Chem. 2003 Sep 5;278(36):33972-7
references.pmid: 12821649
references.citation: J Psychopharmacol. 2006 May;20(3):315-7
references.pmid: 16574702
references.citation: Annu Rev Genet. 2005;39:359-407
references.pmid: 16285865
references.citation: J Psychopharmacol. 2006 May;20(3):456-63
references.pmid: 16574720
references.citation: J Neurosci. 2007 Sep 19;27(38):10203-10
references.pmid: 17881526
references.citation: Gut. 1996 Mar;38(3):454-8
references.pmid: 8675102
references.citation: Lancet. 1998 Nov 28;352(9142):1751-2
references.pmid: 9848354
references.citation: Mol Cells. 2005 Feb 28;19(1):97-103
references.pmid: 15750346
references.citation: Protein Expr Purif. 2004 Jun;35(2):320-6
references.pmid: 15135409
references.citation: J Pharmacol Exp Ther. 1995 May;273(2):667-73
references.pmid: 7538579
references.citation: Psychopharmacology (Berl). 2006 Sep;187(4):467-75
references.pmid: 16830130
references.citation: Eur J Pharmacol. 1997 Apr 4;323(2-3):173-80
references.pmid: 9128836
references.citation: Psychosomatics. 2004 Jan-Feb;45(1):84-7
references.pmid: 14709765
references.citation: Chem Res Toxicol. 2000 Mar;13(3):135-60
references.pmid: 10725110
references.citation: FEBS Lett. 2007 Aug 21;581(21):3967-72
references.pmid: 17673211
references.citation: J Hepatol. 1998 Sep;29(3):394-7
references.pmid: 9764985
references.citation: Toxicology. 2004 Aug 5;200(2-3):193-203
references.pmid: 15212815
references.citation: Free Radic Biol Med. 1992 Oct;13(4):391-405
references.pmid: 1398218
references.citation: Proteomics. 2004 Nov;4(11):3401-12
references.pmid: 15449375
references.citation: Proteomics. 2006 Jan;6(1):4-8
references.pmid: 16400714
references.citation: Ann Epidemiol. 2007 Jan;17(1):74-80
references.pmid: 17140814
references.citation: Liver. 2000 Feb;20(1):8-15
references.pmid: 10726956
references.citation: J Biol Chem. 2002 Mar 22;277(12):9806-11
references.pmid: 11777920
references.citation: J Biol Chem. 2006 Jul 28;281(30):21256-21265
references.pmid: 16709574
references.citation: Hepatology. 2006 Nov;44(5):1218-30
references.pmid: 17058263
references.citation: Free Radic Biol Med. 1999 Jan;26(1-2):3-13
references.pmid: 9890635
references.citation: Biochemistry. 2007 Oct 2;46(39):11090-100
references.pmid: 17824617
references.citation: J Psychoactive Drugs. 2002 Apr-Jun;34(2):163-9
references.pmid: 12691206
references.citation: Eur J Pharmacol. 1988 Oct 26;156(1):121-31
references.pmid: 2463176
references.citation: J Biol Chem. 2003 Sep 26;278(39):37223-30
references.pmid: 12857734
references.citation: Ther Drug Monit. 2004 Apr;26(2):137-44
references.pmid: 15228154
references.citation: Chem Res Toxicol. 2006 Oct;19(10):1294-304
references.pmid: 17040098
references.citation: J Pharmacol Exp Ther. 2005 Feb;312(2):694-701
references.pmid: 15456837
references.citation: Neuropsychopharmacology. 2005 Jul;30(7):1312-23
references.pmid: 15688085
references.citation: J Pharmacol Exp Ther. 2005 Apr;313(1):422-31
references.pmid: 15634943
references.citation: Biochem Soc Trans. 2000 Feb;28(2):177-82
references.pmid: 10816122
references.citation: Eur J Pharmacol. 2004 Oct 1;500(1-3):3-13
references.pmid: 15464016
references.citation: Am J Physiol Gastrointest Liver Physiol. 2004 Apr;286(4):G521-7
references.pmid: 14670822
references.citation: J Biol Chem. 1997 Aug 15;272(33):20313-6
references.pmid: 9252331
references.citation: Biochem Pharmacol. 2004 Mar 15;67(6):1025-33
references.pmid: 15006539
references.citation: Mitochondrion. 2006 Feb;6(1):1-28
references.pmid: 16406828
references.citation: Brain Res Bull. 1992 Jan;28(1):115-9
references.pmid: 1347247
references.citation: Physiol Rev. 2007 Jan;87(1):315-424
references.pmid: 17237348
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11065-70
references.pmid: 9736690
references.citation: J Biol Chem. 2003 Sep 19;278(38):36027-31
references.pmid: 12840017
references.citation: Arch Intern Med. 1999 Oct 11;159(18):2221-4
references.pmid: 10527300
references.citation: Neuroscience. 1999;91(4):1379-87
references.pmid: 10391444
references.citation: Arch Biochem Biophys. 2007 Aug 1;464(1):1-11
references.pmid: 17475207
references.citation: Proteomics. 2006 Feb;6(4):1250-60
references.pmid: 16408314